SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

November 20, 2009 | 
1 min read
Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Hanging questions.Blue background.
Adcomms
FDA Flip-Flops on Scrapping Adcomms
September 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Tariffs
Trump Carves Tariff Exemptions for Some Pharma Products
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
U.S. and Chinese flags in concrete, broken in the middle
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Joint pain anatomy medical concept
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
September 11, 2025
 · 
2 min read
 · 
Tristan Manalac